**Core tip:** In this study, we sought to identify biomarkers that could help predict the risk of postoperative pancreatic fistula (POPF) after pancreaticoduodenectomy. Diagnosis of POPF was based on the International Study Group of Pancreatic Fistula criteria. Association between POPF and various clinical and biochemical parameters was assessed. Amylase level in the abdominal drainage fluid on postoperative day 1 and serum amylase level on postoperative day 4 showed a significant association with POPF and represent novel biomarkers associated with POPF development.

INTRODUCTION
============

Pancreaticoduodenectomy (PD) is a common operative approach for treatment of various malignant diseases of the distal biliary duct, the head of pancreas, and the peri-ampullar region. It is also widely acknowledged as one of the most challenging surgical procedures. PD is associated with substantial perioperative mortality (2%-5% even in high-volume centers) and morbidity (30%-50%)\[[@B1],[@B2]\]. Postoperative pancreatic fistula (POPF) is one of the most important complications of PD; reported incidence rates range from 2% to 25%\[[@B3]\]. POPF often leads to further complications, such as hemorrhage and abdominal abscess, and is associated with increased length of hospital stay\[[@B3],[@B4]\]. POPF and other PD-associated complications have necessitated the development of new surgical modalities, like a combination of pancreaticojejunostomy with duct-mucosa pancreaticojejunostomy; however, the incidence of POPF following PD continues to be a concern\[[@B5]\].

Various pre-operative and intra-operative factors, such as preoperative jaundice and diameter of the pancreatic duct, are associated with POPF; however, these factors are not reliable predictors of POPF\[[@B6],[@B7]\]. Biochemical markers in serum and drainage fluid may reflect the disease progression, and it is of translational significance to investigate their correlation with clinical characteristics and their potential value as predictors of POPF. In this study, we sought to identify potential predictors of POPF development, which may help optimize the treatment of these patients in clinical practice.

MATERIALS AND METHODS
=====================

Study design
------------

We prospectively recruited 83 patients to this study. All patients underwent PD at the Department of Hepatobiliary and Pancreatic Surgery at the First Bethune Hospital of Jilin University between June 2011 and April 2015. Preoperative, intraoperative and postoperative data were collected for each patient. Preoperative variables of interest included age, sex, history of diabetes, jaundice, plasma protein levels and pre-operative intervention for jaundice (if any). Intraoperative variables included pancreatic consistency, diameter of pancreatic duct, and the technique used for pancreatic anastomosis. Postoperative data included the results of pathological examination, pancreatic and gastric drainage volume, and complications after operation, such as POPF, hemorrhage, acute pancreatitis, delayed gastric emptying (DGE), and biliary fistula (Table [1](#T1){ref-type="table"}).

###### 

Definitions of postoperative complications after pancreaticoduodenectomy

  **Complication**   **Definition**
  ------------------ -------------------------------------------------------------------------------------------------------------------------
  POPF               Drainage fluid amylase activity on or after postoperative day 3 is at least three times the upper limit in normal serum
  Ascites            Ultrasound evidence of ascites depth \> 5 cm
  Hemorrhage         Requires postoperative transfusion of ≥ 2 U isogenic red blood cells
  Biliary fistula    Abdominal drainage produces bilious fluid at 50 mL/d after surgery
  DGE                Indwelling stomach tube for \> 10 d

POPF: Postoperative pancreatic fistula; DGE: Delayed gastric emptying.

Severity of POPF was classified as grade A, B or C, as defined by the International Study Group of Pancreatic Fistula\[[@B8]\]. Association between surgical outcomes and results of routine serological and biochemical investigations was assessed. The study protocol complied with the principles of the Declaration of Helsinki, and was approved by the Institutional Ethics Committee at the First Hospital of Jilin University. All patients had provided informed consent prior to their enrolment.

Details of clinical management
------------------------------

Forty-three patients received PD with a pancreatic drainage tube (size: 6, 7 or 8) anastomosed to the pancreatic parenchyma during the pancreaticojejunostomy; the tube was then drawn out through the distal bowel. In the remaining 40 patients, the standard Child's procedure was performed with placement of external pancreatic drainage tube (size: 6, 7 or 8), which was fixed to the pancreatic parenchyma and left in the bowel. All patients were treated with cefoperazone and sulbactam (3.0 g/Q12 h) for the first 4 postoperative days (PODs) to prevent infection. Postoperatively, prophylactic intravenous octreotide was administered at a dose of 0.6 mg/24 h for 3 d to reduce the amount of pancreatic secretion.

Statistical analysis
--------------------

Statistical analyses were conducted using SPSS software (version 19.0; SPSS Inc., IBM, Armonk, NY, United States). Univariate and multivariate analyses were performed to identify factors significantly related to POPF. Receiver operating characteristic (ROC) curve analysis was performed to assess the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the identified variables. A *P* value of less than 0.05 was considered indicative of statistical significance.

RESULTS
=======

Incidence of POPF
-----------------

Out of 83 patients, 28 (33.7%) eventually developed POPF. The severity of POPF was classified as grade A in 8 (28%) patients, grade B in 16 (58%) and grade C in 4 (14%) (Table [2](#T2){ref-type="table"}).

###### 

Summary of postoperative complications

  **Complication**                   **Cases, *n* = 30**   **Incidence, %**
  ---------------------------------- --------------------- ------------------
  POPF                               28                    33.7
  Type A                             8                     28
  Type B                             16                    58
  Type C                             4                     14
  Ascites                            4                     10
  Hemorrhage                         7                     17.5
  Biliary leakage                    1                     2.5
  DGE                                1                     2.5
  Postoperative acute pancreatitis   1                     2.5

POPF: Postoperative pancreatic fistula; DGE: Delayed gastric emptying.

High amylase level predicts POPF development
--------------------------------------------

We first categorized the patients as POPF and non-POPF groups, and then compared the levels of different parameters between the two groups (Table [3](#T3){ref-type="table"}). On univariate analysis, amylase level in the abdominal drainage fluid on POD1 and serum amylase level on PODs 1 and 4 were correlated with POPF development (*P* \< 0.05) (Table [4](#T4){ref-type="table"}).

###### 

General risk factors for pancreatic leakage

  **Variable**                                  **POPF (*n* = 14)**        **Non-POPF (*n* = 26)**   ***t*/*z*/*χ*^2^**   ***P* value**
  --------------------------------------------- -------------------------- ------------------------- -------------------- ---------------------------------------
  Age in yr                                     54.18 ± 6.945              54.04 ± 10.447            0.065                0.948
  Sex                                                                                                                     
  Male                                          20 (71.4)                  32 (58.2)                 1.391                0.337[1](#T3FN1){ref-type="table-fn"}
  Female                                        8 (28.6)                   23 (41.8)                                      
  Blood loss in mL                              300 (200, 575)             200 (200, 600)            -1.266               0.205
  Pancreatic duct diameter in mm                                                                                          
  \> 3                                          11 (39.3)                  33 (60.0)                 3.196                0.104[1](#T3FN1){ref-type="table-fn"}
  \< 3                                          17 (60.7)                  22 (40.0)                                      
  Preoperative low plasma protein                                                                                         
  Yes                                           7 (25.0)                   12 (21.8)                 0.106                0.786[1](#T3FN1){ref-type="table-fn"}
  No                                            21 (75.0)                  43 (78.2)                                      
  Preoperative relief of jaundice                                                                                         
  Yes                                           4 (14.3)                   4 (7.3)                   1.048                0.433[1](#T3FN1){ref-type="table-fn"}
  No                                            24(85.7)                   51 (92.7)                                      
  Preoperative jaundice                                                                                                   
  Yes                                           18 (64.3)                  34 (61.8)                 0.048                1.000
  No                                            10 (35.7)                  21 (38.2)                                      
  Surgical type                                                                                                           
  External drainage of PD                       12 (42.9)                  27 (49.1)                 0.289                0.647[1](#T3FN1){ref-type="table-fn"}
  Internal drainage of PD                       16 (57.1)                  28 (50.9)                                      
  Diabetes                                                                                                                
  Yes                                           2 (7.1)                    0 (0.0)                   4.026                0.111[1](#T3FN1){ref-type="table-fn"}
  No                                            26 (92.9)                  55 (100.0)                                     
  Duration of surgery in min                    267.5 (240.0, 327.5)       280.0 (235.0, 335.0)      -0.082               0.935
  Hospitalization period in days                15.00 (13.00, 18.00)       21.50 (18.00, 27.75)      -4.385               \< 0.001
  Drainage fluid amylase level on POD1 in U/L   6017.5 (2494.5, 11752.5)   890.0 (350.0, 1500.0)     -5.110               \< 0.001
  Serum amylase level in U/L                                                                                              
  POD1                                          379.5 (157.5, 627.5)       124.0 (80.0, 165.0)       -4.091               \< 0.001
  POD4                                          30.0 (30.0, 50.0)          61.5 (45.5, 150.0)        -4.435               \< 0.001
  Serum albumin                                                                                                           
  POD1                                          29.5 (25.3, 34.3)          30.7 (26.6, 33.0)         -0.125               0.900
  POD3                                          30.1 (25.7, 34.6)          30.4 (27.1, 33.2)         -0.111               0.912
  POD5                                          30.8 (27.8, 34.4)          31.4 (28.4, 36.9)         -0.718               0.473
  Choline                                                                                                                 
  POD1                                          4957 (4022, 4957)          5242 (4048, 6715)         -0.876               0.381
  POD3                                          3481 (2626, 4518)          4056 (3345, 5020)         -1.425               0.154
  POD5                                          3268 (2696, 4537)          4024 (3248, 5069)         -1.580               0.114
  WBC count                                                                                                               
  POD1                                          14.73 (10.84, 18.75)       15.49 (12.42, 18.41)      -0.751               0.452
  POD3                                          14.90 (11.74, 18.64)       13.54 (10.34, 16.58)      -1.112               0.266
  POD5                                          11.99 (9.65, 15.56)        11.24 (9.17, 14.79)       -0.510               0.610
  Pathology examination result                                                                       2.445                0.485
  Cholangiocarcinoma                            12 (42.9)                  29 (52.7)                                      
  Pancreatic carcinoma                          3 (10.7)                   8 (14.5)                                       
  Ampullary carcinoma                           3 (10.7)                   7 (12.7)                                       
  Other                                         10 (35.7)                  11 (20.0)                                      

Data are presented as *n* (%).

Fisher's exact test. POPF: Postoperative pancreatic fistula; PD: Pancreaticoduodenectomy; WBC: White blood cell; POD: Postoperative day.

###### 

Results of univariate analysis showing risk factors for postoperative pancreatic fistula

  **Factor**                                                                                  ***β***   **SE**      ***Waldχ*^2^**   **OR (95%CI)**          ***P* value**
  ------------------------------------------------------------------------------------------- --------- ----------- ---------------- ----------------------- ---------------
  Age in yr                                                                                   0.023     0.037       0.397            1.024 (0.952-1.101)     0.529
  Sex, female/male                                                                            -0.586    0.500       1.375            0.557 (0.209-1.482)     0.241
  Blood loss in mL                                                                            0.000     0.001       0.257            1.000 (0.999-1.001)     0.612
  Pancreatic duct diameter,                                                                   -0.841    0.475       3.135            0.431 (0.170-1.094)     0.077
  \> 3 mm/\< 3 mm                                                                                                                                            
  Preoperative low plasma protein, yes/no                                                     0.178     0.545       0.106            1.194 (0.410-3.476)     0.744
  Preoperative relief of jaundice, yes/no                                                     0.754     0.749       1.012            2.125 (0.489-9.227)     0.314
  Preoperative jaundice, yes/no                                                               0.106     0.482       0.048            1.112 (0.432-2.861)     0.826
  Internal or External drainage of PD                                                         0.251     0.468       0.289            1.286 (0.514-3.214)     0.591
  Diabetes, yes/no                                                                            21.952    28420.722   0.000            3.417E9 (0.000)         0.999
  Pathology examination result, ampullary carcinoma/pancreatic carcinoma/cholangiocarcinoma   0.241     0.182       1.757            1.273 (0.891-1.819)     0.185
  Duration of surgery in min                                                                  0.000     0.003       0.008            1.000 (0.995-1.005)     0.928
  Drainage fluid amylase level, POD1 \> 5000 U/L                                              0.000     0.000       10.293           1.000 (1.000\--1.000)   0.001
  Serum amylase level                                                                                                                                        
  POD1 \> 140 U/L                                                                             0.004     0.001       9.982            1.004 (1.001-1.006)     0.002
  POD4 \> 140 U/L                                                                             0.013     0.005       7.752            1.013 (1.004-1.022)     0.005
  Serum albumin                                                                                                                                              
  POD1                                                                                        0.000     0.045       0.000            1.000 (0.916, 1.092)    0.994
  POD3                                                                                        -0.006    0.044       0.020            0.994 (0.911, 1.084)    0.887
  POD5                                                                                        -0.023    0.044       0.277            0.977 (0.897, 1.064)    0.599
  Choline                                                                                                                                                    
  POD1                                                                                        -0.016    0.041       0.149            0.984 (0.908, 1.067)    0.700
  POD3                                                                                        0.033     0.046       0.521            1.034 (0.945, 1.131)    0.470
  POD5                                                                                        0.007     0.053       0.016            1.007 (0.908, 1.117)    0.898
  WBC count                                                                                                                                                  
  POD1                                                                                        0.000     0.000       1.153            1.000 (1.000, 1.000)    0.283
  POD3                                                                                        0.000     0.000       1.298            1.000 (0.999, 1.000)    0.255
  POD5                                                                                        0.000     0.000       2.026            1.000 (0.999, 1.000)    0.155

POPF: Postoperative pancreatic fistula; PD: Pancreaticoduodenectomy; WBC: White blood cell; POD: Postoperative day.

Multivariate logistic regression analysis confirmed that amylase level in abdominal drainage fluid on POD1 and serum amylase level on POD4 were independent predictors of POPF (Table [5](#T5){ref-type="table"}). On ROC curve analysis, a cut-off amylase level of 2365.5 U/L in the abdominal drainage fluid on POD1 as predictor of POPF was associated with 78.6% sensitivity, 80% specificity, 66.7% PPV and 88% NPV \[area under the curve (AUC): 0.844; *P* = 0.009\] (Figure [1](#F1){ref-type="fig"}). Similarly, a cut-off serum amylase level of 44.2 U/L on POD4 was associated with a 78.6% sensitivity and 70.9% specificity (AUC: 0.784; *P* = 0.05; Figure [2](#F2){ref-type="fig"}). The specificity of these associations was further highlighted by the observation that neither white blood cell (WBC) counts nor choline and albumin levels correlated with POPF development.

![Receiver operating characteristic curve analysis of amylase activity in drainage fluid. A cut-off value of 2365.5 U/L was associated with 78.6% sensitivity, 80% specificity, 66.7% PPV and 88% NPV for POPF (AUC: 0.844, *P* = 0.009). ROC: Receiver operating characteristic; POPF: Postoperative pancreatic fistula; NPV: Negative predictive value; PPV: Positive predictive value; AUC: Area under the curve.](WJG-23-6357-g001){#F1}

![ROC curve analysis of serum amylase activity. A cut-off value of 44.2 U/L on POD4 was associated with a 78.6% sensitivity and 70.9% specificity for POPF (AUC: 0.784, *P* = 0.05). ROC: Receiver operating characteristic; POPF: Postoperative pancreatic fistula; AUC: Area under the curve.](WJG-23-6357-g002){#F2}

###### 

Results of multivariate logistic regression analysis showing risk factors for postoperative pancreatic fistula

  **Predictor**                          ***β***   **SE**   ***Waldχ*^2^**   **OR (95%CI)**          ***P* value**
  -------------------------------------- --------- -------- ---------------- ----------------------- ---------------
  Amylase level, POD1 \> 5000 U/L        0.000     0.000    6.728            1.000 (1.000\--1.000)   0.009
  Serum amylase, level POD1 \> 140 U/L   0.001     0.002    0.243            1.001 (0.998-1.004)     0.622
  Serum amylase level, POD4 \> 140 U/L   0.009     0.004    3.826            1.009 (1.000-1.017)     0.050

POPF: Postoperative pancreatic fistula; POD: Postoperative day.

DISCUSSION
==========

The Whipple procedure for PD for the treatment of benign and malignant tumors in the head of pancreas and the peri-ampullar region is one of the most technically challenging surgical procedures, with long duration of surgery and a high rate of associated complications\[[@B9],[@B10]\]. The reported rates of postoperative complications following PD range from 30%-70%, and postoperative mortality rates have remained approximately 5% even in high-volume centers\[[@B11]\]. POPF accounts for 2%-25% of all complications of PD\[[@B12]\]. The advent of novel surgical modalities for pancreaticojejunostomy, such as the duct-mucosa pancreaticojejunostomy or pancreatic duct stent implantation, has not resulted in major improvement. Therefore, early detection of POPF development and adequate timely intervention is important to improve surgical outcomes in these patients\[[@B13]-[@B17]\]. There is a paucity of tools to identify patients who are at risk of development of POPF. Here, we report our prospective study to identify potential predictors of POPF. The results suggest that monitoring of amylase levels in drainage fluid and serum as biomarkers is quite promising.

Various factors have been linked to POPF in previous studies. These include pancreatic consistency, pancreatic duct diameter, and the results of assessment by the pathologist\[[@B18]-[@B22]\]; however, their predictive value has been shown to be relatively poor and not intuitive. In the present study, we observed an obvious correlation between amylase levels in the ascitic fluid on POD1 and the serum amylase level on POD4 with the occurrence of POPF. Cloyd et al\[[@B20]\] reported that serum amylase level on POD1 (\> 140 U/L) predicts POPF with 81.5% sensitivity, 55.5% specificity, 29.3% PPV, and 93% NPV\[[@B23]\]. Likewise, some researchers demonstrated that drainage fluid amylase level on POD1 (\> 350 U/L) can predict POPF with a 79% specificity, 100% sensitivity, 41% PPV, and 100% NPV. Furthermore, Popiela et al\[[@B24]\] showed that the drainage fluid amylase level (\> 5000 U/L) on POD1 is a reliable predictor of POPF. Kawai et al\[[@B25]\] also found that the ratio of total amylase in drainage fluid could predict POPF. Our results are consistent with these previous publications, which indicate that amylase level in ascitic fluid on POD1 and blood amylase on POD4 could be used to identify patients who are most likely to suffer from this complication after PD.

Of note, we did not observe a significant association of albumin and WBC counts with POPF. Kawai et al\[[@B25]\] reported that serum albumin levels (\< 3.0 g/d) and serum WBC count (\> 9800 mm^3^) on POD4 predicted grades B and C POPF with a 69% sensitivity, a 96% specificity, an 88% PPV, and an 85% NPV. Relles et al\[[@B26]\] found that serum albumin (\< 2.5 mg/L) and blood urea nitrogen (\> 10 mg/dL) on POD1 were important predictors of perioperative morbidity following PD\[[@B27]\]. However, in our study, the level of serum albumin through POD1, POD3 and POD5 did not correlate with the development of POPF. Considering that acute stress can affect serum albumin level and WBC counts\[[@B28]\], these may not be appropriate measures to gauge the risk of POPF. A prospective trial showed that postoperative albumin levels were not associated with risk during abdominal operation\[[@B29]\]. Welsch et al\[[@B29]\] also reported poor specificity of serum WBC as a predictor of POPF. Our results are consistent with these reports. In addition, no significant association of POPF with cholinesterase level was observed on POD1, POD3 and POD5, which suggests that POPF may not have an obvious relationship with the postoperative change in hepatic reserve.

In our study, a cut-off amylase level of 2365.5 U/L in ascitic fluid on POD1 predicted POPF with 78.6% sensitivity, 80% specificity, 66.7% PPV, and 88% NPV. We hypothesize that in patients with POPF, the higher level of amylase in drainage fluid on POD1 derives from the failed pancreaticojejunal anastomosis, which leads to POPF.

Serum amylase has been used for diagnosis of acute pancreatitis for \> 70 years; however, increased serum amylase levels are also observed in other diseases of salivary glands, oviduct epithelium and proximal duodenum, which limits its specificity for the diagnosis of pancreatitis. Intuitively, this should be less of a concern with respect to drainage fluid or generally following PD\[[@B30]\]. Indeed, in our study, serum amylase on POD4 showed a significant correlation with POPF, although serum amylase on POD1 did not effectively predict POPF. We found that serum amylase on POD4 of 44.2 U/L was an effective maker; however, this value is within the normal range of serum amylase, and thus serum amylase level on POD4 higher than 100 U/L is probably more appropriate. Serum amylase on POD4 with a discriminatory threshold of 100 U/L can predict POPF with 42.9% sensitivity, 55% specificity, 75% PPV, and 76.1% NPV. In the early postoperative stage, ischemic injury to pancreatic tissues caused by surgical damage to blood vessels, intraoperative and postoperative hypovolemia, and surgical stress leads to elevation of serum amylase\[[@B31]\]. However, no statistically significant correlation was observed between serum amylase level on POD1 and pancreatic leakage, and no correlation was found between serum amylase and POPF in theory, whereas absorption of exudates from pancreatic anastomosis cannot explain such a phenomenon. On the other hand, we believe that elevation in serum amylase level on POD4 reflects the preliminary establishment of a collateral pancreatic anastomosis, and that correction of hypovolumia may reflect the condition of pancreatic juice derived from accessory pancreatic duct or residual pancreatic section instead of the obstructed main pancreatic duct. Moreover, the erosion effect of amylopsin and trypsin on blood vessel can also increase the absorption speed and the amount of amylopsin into the blood, which reflects the increased serum amylase. Thus, blood amylase level on POD4 is of certain predictive value for the occurrence of POPF.

In our study, we found that amylase activity in drainage fluid on POD1 and serum amylase activity on POD4 could accurately predict POPF, whereas serum albumin and prealbumin did not show a significant predictive value. Measurement of amylase level in drainage fluid on POD1 and the serum amylase level on POD4 is a relatively easy and economical method. Our results support the use of amylase to predict POPF.

This may allow for timely interventions, such as increased duration of antibiotic and octreotide therapies, that may help prevent POPF and allow for timely risk-communication to the patient. It is also another procedure in the processing carried out in our medical center.
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Identification of patients who are at high risk of postoperative pancreatic fistula (POPF) in the immediate postoperative period after is a key imperative to improve surgical outcomes of pancreaticoduodenectomy (PD). Biochemical markers in serum and drainage fluid may reflect disease progression, and it is of translational significance to investigate their correlation with clinical characteristics and their potential use to predict the risk of POPF. In this study, we sought to identify potential predictors of POPF development, which may help optimize the treatment of such patients in clinical practice.

Research frontiers
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Although anastomosis techniques used for PD significantly improves, the incidence of PD-associated POPF remains relatively high. POPF is a major threat to patients who undergo PD. Thus, early and accurate prediction of POPF is essential to achieve optimal surgical outcomes.
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Previous studies have found several biochemical factors, such as serum amylase level on postoperative day (POD)1, drainage fluid amylase level on POD1, and a combination of serum albumin and leukocyte count as predictors of POPF. However, some of these markers have low positive predictive value. We demonstrate that amylase level in drainage fluid on POD1 and serum amylase level on POD4 are better predictors of POPF than those proposed earlier.

Applications
------------

Measurement of amylase level in serum and drainage fluid is relatively straightforward and inexpensive. These two investigations can help identify patients who are at an increased risk of POPF. This may allow for timely interventions, such as increased duration of antibiotic and octreotide therapies, that may help prevent POPF. It is also another procedure in the processing carried out in our medical center.
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Although several biochemical factors have been shown to predict POPF in previous studies, we found that just amylase levels in drainage fluid on POD1 and serum amylase level on POD4 could accurately predict POPF, whereas serum albumin and prealbumin were found to have negligible predictive value.
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